| 1 |
35393219 | Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers. | 2022 May 1 |
1 |
| 2 |
33389242 | A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death. | 2021 Jan 3 |
1 |
| 3 |
33813001 | Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase. | 2021 Jul 1 |
1 |
| 4 |
34619528 | Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiation. | 2021 Nov |
2 |
| 5 |
34906277 | Evaluation of Poly(ADP-ribose) Polymerase Inhibitor, Pamiparib (BGB-290) in Treating Acute Myeloid Leukemia and the Characterization of Its Nanocarrier. | 2021 Nov 1 |
3 |
| 6 |
31420991 | NRF2/ABCB1-mediated efflux and PARP1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells. | 2020 Feb |
3 |
| 7 |
31989039 | CRISPR/Cas9-mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1-mutated breast cancer cells. | 2020 Jan |
1 |
| 8 |
32055930 | Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up. | 2020 Apr |
1 |
| 9 |
32061787 | A dual PI3 kinase/mTOR inhibitor BEZ235 reverses doxorubicin resistance in ABCB1 overexpressing ovarian and pancreatic cancer cell lines. | 2020 Jun |
1 |
| 10 |
32345117 | Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1. | 2020 Dec |
4 |
| 11 |
32919690 | Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy. | 2020 Dec |
2 |
| 12 |
30326402 | Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity. | 2019 Feb |
2 |
| 13 |
30431088 | PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis. | 2019 Jan |
1 |
| 14 |
30448557 | Poly(ADP-ribose) polymerase-1 promotes expression of miR-155 by the up-regulation of methyl-CpG binding domain protein 2 in TK6 cells exposed to hydroquinone. | 2019 Mar |
2 |
| 15 |
30937974 | Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway. | 2019 Jun |
1 |
| 16 |
31215481 | MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. | 2019 Jun 18 |
1 |
| 17 |
31861131 | Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling. | 2019 Dec 17 |
1 |
| 18 |
29254044 | pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells. | 2018 Feb 1 |
1 |
| 19 |
29309757 | Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK. | 2018 Feb |
1 |
| 20 |
29784019 | The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma. | 2018 May 21 |
2 |
| 21 |
29959912 | SAHA and cisplatin sensitize gastric cancer cells to doxorubicin by induction of DNA damage, apoptosis and perturbation of AMPK-mTOR signalling. | 2018 Sep 15 |
2 |
| 22 |
30166110 | Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. | 2018 Aug 1 |
2 |
| 23 |
28222632 | Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity. | 2017 Feb |
1 |
| 24 |
28498322 | Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells. | 2017 May 12 |
1 |
| 25 |
28653879 | TP53 alteration determines the combinational cytotoxic effect of doxorubicin and an antioxidant NAC. | 2017 Jun |
1 |
| 26 |
28791810 | Cytotoxicity of anticancer drugs and PJ-34 (poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor) on HL-60 and Jurkat cells. | 2017 May-Jun |
1 |
| 27 |
28827731 | MicroRNA-7641 is a regulator of ribosomal proteins and a promising targeting factor to improve the efficacy of cancer therapy. | 2017 Aug 21 |
2 |
| 28 |
29201109 | Evaluation of Apoptosis in Multipotent Hematopoietic Cells of Bone Marrow by Anthracycline Antibiotics. | 2017 Summer |
3 |
| 29 |
26505786 | Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. | 2016 Jan 11 |
2 |
| 30 |
26525975 | Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 Channels. | 2016 Apr |
1 |
| 31 |
26943039 | Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response. | 2016 Apr 5 |
3 |
| 32 |
27565811 | Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells. | 2016 Oct |
2 |
| 33 |
27898232 | Unfolded Protein Response Promotes Doxorubicin-Induced Nonsmall Cell Lung Cancer Cells Apoptosis via the mTOR Pathway Inhibition. | 2016 Dec |
1 |
| 34 |
25938539 | PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression. | 2015 Jun 20 |
3 |
| 35 |
26101222 | Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity. | 2015 Sep |
1 |
| 36 |
26438158 | PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway. | 2015 Dec |
1 |
| 37 |
26522181 | Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53. | 2015 Nov 2 |
6 |
| 38 |
26881525 | Doxorubicin enhances (131)I-rituximab induced cell death in Raji cells. | 2015 Oct-Dec |
1 |
| 39 |
24245692 | Suppression of NF-κB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin -induced apoptosis in lung cancer. | 2014 |
1 |
| 40 |
24247637 | Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt. | 2014 Jan |
1 |
| 41 |
24675890 | Doxorubicin enhances Snail/LSD1-mediated PTEN suppression in a PARP1-dependent manner. | 2014 |
4 |
| 42 |
24811541 | Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells. | 2014 Aug 4 |
1 |
| 43 |
24998637 | Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. | 2014 Sep 5 |
3 |
| 44 |
25066396 | Inhibited effects of veliparib combined doxorubicin for BEL-7404 proliferation of human liver cancer cell line. | 2014 Jun |
1 |
| 45 |
25168906 | Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs. | 2014 Aug 29 |
1 |
| 46 |
25337234 | Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells. | 2014 |
5 |
| 47 |
25367122 | Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells. | 2014 Nov 3 |
1 |
| 48 |
25377255 | The role of Kif4A in doxorubicin-induced apoptosis in breast cancer cells. | 2014 Nov |
5 |
| 49 |
23503641 | Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro. | 2013 May |
1 |
| 50 |
23582862 | Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. | 2013 Jul |
1 |